Hypertension is a leading cause of death worldwide. 1 Overweight caused by adipose tissue is a major risk factor for hypertension, 2,3 and indeed overweight and hypertension are disorders that are closely interrelated, but the mechanisms remain elusive. 2,3 During the past decades, it has become clear that adipose tissue is not just an inactive energy-storing organ. 2,3 Quite the opposite, adipose tissue is an endocrine organ that secretes hormones and cytokines with vascular and inflammatory effects, and it has been suggested that these molecules play a pivotal role in overweight-related diseases, including hypertension. [2][3][4] Leptin and adiponectin are two such adipocyte-derived hormones, and both hormones are candidate intermediaries between adipose tissue and overweight-related disorders. [2][3][4][5][6] Interestingly, leptin and adiponectin are oppositely associated with a series of cardiometabolic risk factors. Leptin is positively correlated with body mass index (BMI), waist circumference, triglycerides, markers of inflammation, and glucose, and negatively with insulin sensitivity and high-density lipoprotein cholesterol (HDL-C), 2-7 whereas adiponectin is negatively correlated with BMI, waist circumference, triglycerides, markers of inflammation, and glucose, and positively with insulin sensitivity and HDL-C. 2-7 Because of these relationships, hyperleptinemia and hypoadiponectinemia have been linked with the metabolic syndrome and cardiovascular injury. [2][3][4][5][6] With respect to the role of leptin and adiponectin in the development of hypertension, the situation is less clear. Hyperleptinemia was associated with greater risk of newonset hypertension in one study, 8 but not in another. 9 In two prospective studies, including women and men of Asian origin, hypoadiponectinemia was associated with incident Background Leptin and adiponectin are hormones secreted by adipose tissue, and both hormones are candidate intermediaries between adipose tissue and overweight-related diseases. So far, no prospective study has been published where the independent effects of these two hormones on the development of hypertension have been directly compared. The objective of this study was to investigate the relationships between plasma levels of leptin and adiponectin and new-onset hypertension in the copenhagen city heart Study (cchS).